Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02990416 |
Title | A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma |
Recruitment | Unknown status |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Angimmune LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |